Responses
Regular and young investigator award abstracts
Clinical trials in progress
420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study
Compose a Response to This Article
Other responses
No responses have been published for this article.